Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
AstraZeneca
Baxter
Boehringer Ingelheim
Argus Health
Dow
US Army
Fish and Richardson
UBS
Moodys

Generated: February 20, 2018

DrugPatentWatch Database Preview

TAGAMET HB 200 Drug Profile

« Back to Dashboard

Which patents cover Tagamet Hb 200, and when can generic versions of Tagamet Hb 200 launch?

Tagamet Hb 200 is a drug marketed by Glaxosmithkline and is included in one NDA.

The generic ingredient in TAGAMET HB 200 is cimetidine. There are twenty-five drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the cimetidine profile page.
Drug patent expirations by year for TAGAMET HB 200
Medical Subject Heading (MeSH) Categories for TAGAMET HB 200

US Patents and Regulatory Information for TAGAMET HB 200

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline TAGAMET HB 200 cimetidine SUSPENSION;ORAL 020951-001 Jul 9, 1999 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Covington
Argus Health
Colorcon
Dow
Daiichi Sankyo
Teva
UBS
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot